News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Jubilant HollisterStier growth pushes to lead Spokane
Jubilant HollisterStier, led by CEO and president Chris Preti, is undergoing a significant expansion and projects to become the No. 1 biomanufacturer in Spokane, Washington.
A Day in the Life of a Lundbeck Biologics Formulation Scientist
Greg Barnett did not envision being part of the life science industry when he graduated from Lehigh University with a bachelor’s degree in chemical engineering.
Cyrus Biotech spins out company to expand reach of versatile drug development software
Cyrus Biotechnology, a Seattle-based software-enabled biotechnology startup focused on autoimmune diseases, announced it will be spinning out a new for-profit subsidiary named, Levitate Bio. The
Allen Institute’s cell lines could lead to new drugs for hypertrophic cardiomyopathy
The Allen Institute, a Seattle-based research institute, has introduced new stem cell lines that could help scientists identify personalized treatment approaches for Hypertrophic cardiomyopathy (HCM),
Report: Seattle Area Among Top 25 Fastest-Growing Markets for Life-Sciences Talent
According to CBRE’s third-annual U.S. Life Sciences Talent Trends report, the Seattle area ranks as a top market for life science graduates. The report notes a 15.1%
Microsoft, Providence and UW make use of generative AI for digital cancer diagnosis
Researchers at Microsoft, Providence Health System and the University of Washington have developed a new artificial intelligence model for diagnosing cancer, based on an analysis
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
According to data from a recently released late-stage trial, treatment with Bristol Myers Squibb’s immunotherapies, Opdivo and Yervoy, had better outcomes for patients than the
NVIDIA and top VC firms invest in Vilya, a biotech spinout from Seattle’s Institute for Protein Design
Vilya, a biotech startup built from technology developed at the Seattle-based Institute for Protein Design (IPD), announced an expanded $71 million Series A investment round. The
WRF awards more than $2 million in grants to support the development of plans for life-science initiatives in the state
Washington Research Foundation (WRF) awarded nearly $2.2 million in grants to 12 teams at Fred Hutch, Seattle Hub for Synthetic Biology, University of Washington, and
Executive Perspective: Transforming Cancer Research through Collaboration and Innovation
Kamran Ansari, Senior Vice President and Head of Oncology Clinical Development & Operations at Pfizer in the greater Seattle area, shares his perspective on the
AGC Biologics and BioConnection Partner to Offer Drug Product Services
AGC Biologics, a global contract development and manufacturing organization based in Seattle, announced a new partnership with BioConnection, a specialized contract manufacturing organization, to provide
Seattle’s economic strength helps propel it to No. 6 in new ranking of top 1,000 global cities
According to the first-ever “Global Cities Index” report from Oxford Economics, Seattle ranks No. 6 out of 1,000 of the world’s largest cities. The ranking